Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | ADH1B | P00325 | 1/20 | 0.36 |
| ▸ | ADH1C | P00326 | 1/20 | 0.36 |
| ▸ | ADH1A | P07327 | 1/20 | 0.36 |
| ▸ | ADH4 | P08319 | 1/20 | 0.36 |
| ▸ | ADH7 | P40394 | 1/20 | 0.36 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.36 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL5138360 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| Bromide SCHEMBL3217101 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| Bromide SCHEMBL489783 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| Bromide SCHEMBL923748 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| Bromide SCHEMBL139792 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| Bromide SCHEMBL924077 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| Bromide SCHEMBL3092841 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| Bromide SCHEMBL923753 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| Bromide SCHEMBL5088250 | 1.00 | OPRM1 (0.46) | OPRM1SPHK1DNM1LMNATP53 | |
| SCHEMBL8383457 | 0.98 | OPRM1 (0.48) | OPRM1SPHK1DNM1LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 784 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4682160-A1 | PROTEIN AND VACCINE AGAINST INFECTIONS OF SARS-COV-2 OMICRON MUTANT STRAIN XBB AND SUBTYPE THEREOF | WestVac Biopharma Co., Ltd. (CN) | 2026-01-21 | — | — | EP | claimed |
| EP-4656649-A1 | ANTI-ACNE RECOMBINANT PROTEIN VACCINE, PREPARATION METHOD, AND USE | WestVac Biopharma Co., Ltd. (CN) | 2025-12-03 | — | — | EP | claimed |
| EP-4653454-A1 | PROTEIN AND VACCINE FOR RESISTING INFECTION FROM SARS-COV-2 OMICRON MUTANT STRAIN AND SUBTYPE THEREOF | WestVac Biopharma Co., Ltd. (CN) | 2025-11-26 | — | — | EP | claimed |
| EP-4653011-A1 | PREPARATION AND USE OF MRNA VACCINE AND RECOMBINANT PROTEIN SUBUNIT VACCINE AGAINST SARS-COV-2 OR MUTANT | WestVac Biopharma Co., Ltd. (CN) | 2025-11-26 | — | — | EP | claimed |
| CN-119970640-A | Novel nucleic acid delivery system based on phosphatidylmitoxantrone and preparation method and application thereof | 华东理工大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119792238-A | Nucleic acid nano preparation with long-term stability and preparation method and application thereof | 华南理工大学 | 2025-04-11 | — | — | CN | claimed |
| CN-115368264-B | Compounds, liposomes and uses thereof | 北京理工大学 | 2025-03-07 | — | — | CN | claimed |
| WO-2025036230-A1 | PROTEIN, ADENOVIRUS AND VACCINE AGAINST INFECTION OF SUBTYPE OF SARS-COV-2 OMICRON MUTANT STRAIN XBB | 成都威斯克生物医药有限公司 | 2025-02-20 | — | — | WO | claimed |
| EP-4021735-B1 | METHOD FOR TESTING THE RESISTANCE OF DATA CARRIERS AND SECURITY DOCUMENTS | BUNDESDRUCKEREI GMBH (DE) | 2025-02-12 | — | — | EP | claimed |
| US-20240402058-A1 | SYSTEMS AND METHODS FOR PERFORMING A REAL-TIME ASSAY OF A SAMPLE | AMGEN INC. (US) | 2024-12-05 | — | — | US | claimed |
| JP-2003505565-A | — | — | 2003-02-12 | — | — | JP | claimed |
| US-20020160359-A1 | Stabilizing diluent for polypeptides and antigens | GENECARE MEDICAL GENETICS CENTER, INC. | 2002-10-31 | — | — | US | claimed |
| EP-1242576-A1 | STABILIZING DILUENT FOR POLYPEPTIDES AND ANTIGENS | Thermo Biostar, Inc. (US) | 2002-09-25 | — | — | EP | claimed |
| US-20020076813-A1 | Stabilizing diluent for polypeptides and antigens | ALERE SAN DIEGO, INC. (FKA BIOSITE INC. OR FKA CHOLESTECH CORP. OR FKA HEMOSENSE INC. OR FKA INVERNESS MEDICAL-BIOSTAR INC. OR FKA ISCHEMIA TECHNOLOGIES, INC. OR FKA TWISTDX, INC.) | 2002-06-20 | — | — | US | claimed |
| EP-1204699-A1 | PULLULAN FILM COMPOSITIONS | WARNER-LAMBERT COMPANY (US) | 2002-05-15 | — | — | EP | claimed |
| EP-1157691-A1 | Pullulan film compositions with improved surface properties | WARNER-LAMBERT COMPANY (US) | 2001-11-28 | — | — | EP | claimed |
| WO-2001044441-A1 | STABILIZING DILUENT FOR POLYPEPTIDES AND ANTIGENS | THERMO BIOSTAR, INC. (US) | 2001-06-21 | — | — | WO | claimed |
| WO-2001007507-A1 | PULLULAN FILM COMPOSITIONS | WARNER-LAMBERT COMPANY (US) | 2001-02-01 | — | — | WO | claimed |
| US-4472283-A | QUATERNARY AMMONIUM COMPOUNDS TO SLOW LOSS OF CARBON DIOXIDE | CITICORP. USA, INC. | 1984-09-18 | — | — | US | claimed |
| EP-0010577-B1 | METHOD FOR THE REDUCTION OF THE DISTURBANCE OF PHOTOMETRIC MEASUREMENTS BY LIGHT SCATTER IN A SUSPENSION TO BE MEASURED AND REAGENT FOR CARRYING OUT THE METHOD | CONTRAVES AG (CH) | 1981-11-11 | — | — | EP | claimed |